drug
ZILBRYSQ
updated 6mo agoby UCB SA
community read0 votes
🐶 often sniffed alongside
top 2all catalysts(0)
nothing on the calendar yet
News(1)
- Argenx to buy peptide platform in potentially billion-dollar dealFor $550 million up front, Argenx will take control of Unnatural Products’ “macrocyclic peptide” technology and direct it to develop oral, durable medicines for serious immune-mediated diseases.biopharma_dive · 10d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that